The acquisition expands KatRisk's multi-peril catastrophe modeling capabilities and accelerates the development of a high-fidelity earthquake offering for global clients. RED's European earthquake ...
Anthropic announced that it has started a very limited test of its newest AI model called Mythos. It's a model deemed so ...
Renew Risk, a specialist provider of risk analytics for renewable energy assets, has announced the release of its UK & ...
Catastrophe risk software provider KatRisk has acquired RED, a specialist provider of catastrophe models, including earthquake, flood, landslide, and wind ...
NEW YORK--(BUSINESS WIRE)--Ultimate Risk Solutions (“URS”) is proud to announce its important contribution into assisting Uzbekinvest Export-Import Insurance Company of Uzbekistan (“Uzbekinvest”) in ...
The gap between AI and traditional risk modelling is substantial. Traditional models often fall short when dealing with complex, non-linear relationships. In contrast, AI models thrive in detecting ...
Morning Overview on MSN
Study finds Yellowstone magma source is shallower, shifting risk models
Beneath the geysers and hot springs that draw roughly 4.5 million visitors to Yellowstone each year, a pocket of magma sits ...
The LIFE-T1D model, demonstrated an ability to estimate the lifetime risk of heart disease among several groups of people with type 1 diabetes (T1D). Researchers have developed a tool they say can ...
This Collection invites submissions on the latest research in tsunami modelling and risk assessment, including multidisciplinary and integrative studies. We will consider original contributions ...
As financial institutions increasingly integrate AI, they encounter the challenge of unlocking its potential while ensuring compliance with regulatory requirements and ethical standards. In this post, ...
Forbes contributors publish independent expert analyses and insights. Monica Sanders covers climate justice and sustainability from the DMV. As climate change accelerates, so does the need for ...
Researchers validated the performance of the PREDICT-HFpEF tool in the FINEARTS-HF trial (2020-2023), which assessed the efficacy and safety of finerenone in patients with HFmrEF/HFpEF. A total of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results